Fever with Cough

Fever with Cough (Acute Respiratory Infection)

Clinical Scenario A 2-year-old girl presents with a 3-day history of high fever, cough, and runny
nose. Today, her mother noticed she is breathing very quickly and seems more tired than usual.
On examination, her temperature is 39.5°C (103.1°F). Her respiratory rate is 55 breaths per
minute, and she exhibits lower chest indrawing. Auscultation reveals crackles in the right lower
lung base. This presentation of fever, cough, fast breathing, and chest indrawing is classic for
pneumonia, requiring prompt antibiotic therapy and careful monitoring.

Definition "Fever with cough" is one of the most common symptom complexes in pediatric
medicine, typically indicating an acute respiratory tract infection. Fever is defined as a
temperature $\ge$38.0°C (100.4°F). Cough is a reflex response of the lower respiratory tract to
stimulation of irritant receptors in the airway mucosa. The Integrated Management of Childhood
Illness (IMCI) guidelines utilize "cough or difficult breathing" as a primary entry point to
systematically assess children for severe, life-threatening respiratory diseases.

Etiology / Classification Fever with cough can originate from the upper or lower respiratory
tract:

● Upper Respiratory Infections (URIs):

○ Common Cold / Rhinosinusitis: Caused by Rhinoviruses (most frequent),
Adenoviruses, and endemic Coronaviruses.
○ Croup (Laryngotracheobronchitis): Primarily caused by Parainfluenza viruses
(types 1, 2, 3), leading to subglottic swelling.
● Lower Respiratory Infections (LRIs):
○ Bronchiolitis: Primarily caused by Respiratory Syncytial Virus (RSV) and Human
Metapneumovirus (HMPV).
○ Pneumonia: Viral causes include RSV, Influenza A/B, and SARS-CoV-2 (COVID-
19). Bacterial causes include Streptococcus pneumoniae (most common
bacterial cause), Haemophilus influenzae type b, Staphylococcus aureus, and
atypical organisms like Mycoplasma pneumoniae.
● Systemic / Vaccine-Preventable Infections:
○ Measles: Presents with fever, cough, coryza, and conjunctivitis prior to the rash.
○ Pertussis: Cough is prominent, though fever is often absent or low-grade unless
a secondary bacterial infection occurs.

Epidemiology Viral respiratory infections are the most common cause of fever in children.
Respiratory tract infections account for the majority of illnesses in childcare settings. Pathogens
like RSV, Influenza, and Parainfluenza have distinct seasonal epidemic patterns, heavily
peaking in the fall and winter months.

Pathophysiology Viruses or bacteria invade the respiratory epithelium, inducing an acute

inflammatory response characterized by the release of cytokines. This leads to mucosal edema,
excessive mucus production, and sloughing of epithelial cells into the airway. This combination
obstructs airflow and triggers cough receptors. Systemic circulation of inflammatory mediators
concurrently raises the hypothalamic temperature set-point, producing fever.
Clinical Features & Triage The physical examination must focus heavily on assessing the
child's work of breathing and oxygenation.

● Determine Fast Breathing: The WHO IMCI defines fast breathing based on age
cutoffs: $\ge$60 breaths/min for infants <2 months; $\ge$50 breaths/min for 2 to 11
months; and $\ge$40 breaths/min for children 1 to 5 years.
● Assess Respiratory Distress: Look for lower chest indrawing (the lower chest wall
goes in when the child breathes in), nasal flaring, and grunting.
● Auscultation: Stridor (a harsh, high-pitched inspiratory sound) suggests upper airway
obstruction like croup. Wheezing indicates lower airway narrowing, common in
bronchiolitis and asthma. Crackles/rales localized to one area strongly suggest
pneumonia.

Differential Diagnosis

Condition Key Differentiating Features

Common Cold (Viral Runny/stuffy nose, scratchy throat; fever is mild or absent; no
URI) fast breathing or chest indrawing.

Croup Barking/brassy cough, hoarseness, and inspiratory stridor,

usually worse at night.

Bronchiolitis Occurs in infants; presents with tachypnea, retractions,

prolonged expiration, and diffuse wheezing.

Pneumonia (Bacterial) High fever (>38.5°C), rapid breathing, focal crackles, and chest
indrawing; child often appears toxic.

Atypical Pneumonia (M. Older child/adolescent; insidious onset of headache, malaise,

pneumoniae) low-grade fever, and a prominent, worsening dry cough.

Measles Cough accompanied by Koplik spots, conjunctivitis, coryza, and

a descending maculopapular rash.

Investigations and Findings

● Mild / Uncomplicated Cases: Routine laboratory studies and chest X-rays are not
helpful and are not recommended for simple viral URIs or mild bronchiolitis.
● Suspected Pneumonia / Severe Disease: Pulse oximetry is essential to detect hypoxia
(<90% saturation indicates need for urgent referral and oxygen).
● Chest Radiograph: May show lobar consolidation (suggests bacterial pneumonia),
patchy infiltrates with hyperinflation (suggests viral pneumonia or bronchiolitis), or hilar
adenopathy (suggests Tuberculosis).
● Laboratory Tests: In toxic-appearing children, a complete blood count (CBC) showing
marked leukocytosis (e.g., >15,000/mm³) with neutrophil predominance suggests a
bacterial etiology. Multiplex PCR swabs can accurately identify respiratory viruses
(Influenza, RSV, SARS-CoV-2) and atypical bacteria (Mycoplasma).
Management and Treatment

● Supportive Care (Home Management): For mild coughs and colds, ensure adequate
fluid intake and continue breastfeeding/feeding. Treat fever and pain with paracetamol
(acetaminophen) or ibuprofen. Soothe the throat with safe remedies, such as honey in
warm water for children >1 year old. Avoid over-the-counter cough and cold syrups
containing codeine, antihistamines, or decongestants in young children, as they are
ineffective and potentially harmful.
● Pneumonia: For non-severe pneumonia (fast breathing without general danger signs),
give oral antibiotics (such as Amoxicillin) for 5 days. Severe pneumonia requires urgent
hospital referral, securing the airway, oxygen support, and parenteral antibiotics (e.g.,
Ceftriaxone or Ampicillin).
● Wheezing: If wheezing is present, administer an inhaled bronchodilator (e.g.,
salbutamol/albuterol) for 5 days.
● Croup: Mainstay treatment is a dose of corticosteroids (e.g., oral or IM Dexamethasone
0.6 mg/kg). Severe cases with resting stridor require nebulized racemic epinephrine and
hospital observation.

Prognosis The vast majority of febrile cough illnesses are self-limiting viral infections that
resolve without sequelae within 1 to 2 weeks (though the cough may linger slightly longer). The
prognosis for treated bacterial pneumonia is excellent, with fever and clinical symptoms typically
improving within 48 to 72 hours of appropriate antibiotic initiation.
Community-Acquired Pneumonia (CAP)
Community-Acquired Pneumonia (CAP)

Clinical Scenario A 3-year-old girl is brought to the emergency department with an abrupt
onset of high fever, restlessness, and severe respiratory distress. She had a mild runny nose
and cough for two days prior. On examination, she appears toxic and is breathing at 65 breaths
per minute. She exhibits nasal flaring, expiratory grunting, and prominent intercostal and
subcostal retractions. Auscultation reveals diminished breath sounds and focal crackles in the
right lower lung field. Her oxygen saturation is 88% on room air. This classic presentation
strongly suggests severe bacterial pneumonia requiring immediate hospitalization, supplemental
oxygen, and intravenous antibiotics.

Definition Pneumonia is defined as an inflammation of the lung parenchyma. It is the leading

infectious cause of death globally among children younger than 5 years of age.

Etiology / Classification The etiology of pneumonia in children is strongly correlated with the
patient's age:

● Neonates (<3 weeks): Group B streptococcus, E. coli, other gram-negative bacilli, S.

pneumoniae, and Haemophilus influenzae.
● 3 weeks to 3 months: Respiratory syncytial virus (RSV) and other respiratory viruses
are common. Bacterial causes include S. pneumoniae and H. influenzae. Chlamydia
trachomatis should be considered in afebrile infants.
● 4 months to 4 years: Respiratory viruses (RSV, rhinovirus, human metapneumovirus,
influenza, adenovirus) are highly prevalent. ** S. pneumoniae is the most common
bacterial pathogen** in this age group, followed by H. influenzae, Mycoplasma
pneumoniae, and Group A streptococcus (GAS).
● $\ge$5 years: ** M. pneumoniae and Chlamydophila pneumoniae** are the most
frequent bacterial pathogens, along with S. pneumoniae.

Epidemiology Pneumonia accounted for an estimated 880,000 deaths in children younger than
5 years in 2015, with more than 99% of these deaths occurring in low- and middle-income
countries. In the United States, child mortality from pneumonia declined by 97% between 1939
and 1996. This dramatic reduction is attributed to the development of antibiotics and the
widespread use of vaccines against measles, pertussis, H. influenzae type b (Hib), and
pneumococcus (PCV).

Pathophysiology Pneumonia results from the disruption of the complex lower respiratory
ecosystem and host immune defenses.

● Viral Pneumonia: Results from the spread of infection along the respiratory epithelium.
This causes airway obstruction from mucosal swelling, abnormal secretions, and
sloughed cellular debris. Viral infection alters normal secretions and disrupts microbial
communities, frequently predisposing the child to secondary bacterial infections.
● Bacterial Pneumonia: Typically occurs when upper respiratory tract organisms gain
access to the lungs, or occasionally via hematogenous seeding.
○ S. pneumoniae produces local edema that aids in the rapid proliferation and
spread of organisms into adjacent portions of the lung, typically resulting in
characteristic lobar consolidation.
○ S. pyogenes (GAS) causes diffuse interstitial pneumonia with necrosis, vast
exudate, and local hemorrhage.
 ○ Staphylococcus aureus manifests as confluent bronchopneumonia characterized
by extensive hemorrhagic necrosis and cavitation, leading to pneumatoceles,
empyema, and bronchopulmonary fistulas.

Clinical Features

● Tachypnea is the most consistent clinical manifestation of pneumonia.

● Illness is frequently preceded by several days of upper respiratory tract symptoms
(rhinitis, cough).
● Increased work of breathing is prominent, manifesting as intercostal, subcostal, and
suprasternal retractions; nasal flaring; and the use of accessory muscles.
● Infants: May present with an abrupt onset of fever, apprehension, and severe
respiratory distress (grunting, cyanosis) out of proportion to auscultatory findings.
Gastrointestinal disturbances (vomiting, anorexia, diarrhea, abdominal distention from
ileus) are also common.
● Older Children: Bacterial pneumonia usually begins suddenly with high fever, cough,
and chest pain. The child may splint on the affected side (lying on one side with knees
drawn up) to minimize pleuritic pain.
● Physical Exam: Early signs include diminished breath sounds, scattered crackles, and
rhonchi. As consolidation develops, dullness to percussion and a lag in respiratory
excursion may occur.

Differential Diagnosis / Recurrent Pneumonia Clinically differentiating viral from bacterial or

atypical pneumonia is often very difficult. If a child presents with recurrent pneumonia (defined
as $\ge$2 episodes in a single year or $\ge$3 episodes ever, with radiographic clearing
between episodes), underlying predispositions must be aggressively evaluated.

● Differential for Recurrent Pneumonia: Cystic fibrosis, sickle cell disease, primary
immunodeficiencies (e.g., severe combined immunodeficiency, agammaglobulinemia,
chronic granulomatous disease), primary ciliary dyskinesia, anatomic malformations
(pulmonary sequestration, congenital pulmonary airway malformation,
tracheoesophageal fistula), and recurrent aspiration.

Investigations and Findings

● Chest Radiograph: Supports the diagnosis and is crucial for identifying complications
like pleural effusion or empyema. Viral pneumonia often shows hyperinflation, bilateral
interstitial infiltrates, and peribronchial cuffing. Pneumococcal pneumonia classically
shows confluent lobar consolidation. Notably, routine chest radiographs are not
recommended for mild, uncomplicated suspected pneumonia managed in the
outpatient setting.
● Lung Ultrasound: A highly sensitive and specific point-of-care tool for identifying lung
consolidations, air bronchograms, and pleural effusions, completely avoiding ionizing
radiation.
● Laboratory Tests: In viral pneumonia, the WBC count is usually normal or mildly
elevated (<20,000/mm³) with a lymphocyte predominance. Bacterial pneumonia is often
associated with a WBC count of 15,000–40,000/mm³ and a polymorphonuclear
predominance.
● Blood Cultures: Positive in only ~10% of pneumococcal cases. They are not
recommended for non-toxic outpatients but should be obtained in children who require
hospitalization, have complicated pneumonia, or fail to improve.
Complications Most complications arise from the direct spread of the bacterial infection within
the thoracic cavity, leading to pleural effusion, empyema, and pericarditis. Necrotizing
pneumonia, lung abscesses, and pneumatoceles are particularly common with S. aureus or
severe pneumococcal disease. Hematologic spread can rarely result in meningitis, suppurative
arthritis, osteomyelitis, or endocarditis.

Management and Treatment

● Outpatient Therapy (Mild/Uncomplicated): High-dose amoxicillin (90 mg/kg/day

orally divided twice daily) is the recommended first-line therapy for preschool children to
overcome penicillin-resistant pneumococci. For school-age children and adolescents
(where M. pneumoniae or C. pneumoniae are heavily suspected), a macrolide (such as
azithromycin) is the treatment of choice.
● Indications for Hospitalization: Age <6 months, immunocompromised state, toxic
appearance, moderate to severe respiratory distress, hypoxemia (O2 saturation <90%
on room air), complicated pneumonia, severe dehydration, or failure of outpatient oral
antibiotics.
● Inpatient Therapy:
○ Fully immunized children who are not severely ill: Ampicillin or Penicillin G.
○ Incompletely immunized children or those with severe, life-threatening infection
(including empyema): Ceftriaxone or Cefotaxime.
○ If S. aureus (MRSA) is suspected (e.g., pneumatoceles, rapid progression): Add
Vancomycin or Clindamycin.
○ If atypical pneumonia is suspected: Add a macrolide.
● Duration: Antibiotics are generally continued until the patient has been afebrile for 72
hours. Short courses (5–7 days) are often effective for uncomplicated outpatient
pneumonia.

Prognosis Patients with uncomplicated community-acquired bacterial pneumonia typically

show clinical improvement (resolution of fever, improved work of breathing, and decreased
cough) within 48 to 72 hours of initiating appropriate antibiotics. Radiographic clearing lags
substantially behind clinical improvement. If a patient fails to improve, the clinician must urgently
evaluate for complications (e.g., empyema, abscess), bacterial resistance, nonbacterial
etiologies (viruses, fungi, foreign body aspiration), or underlying preexisting diseases like cystic
fibrosis. While mortality is rare in developed nations, it remains a severe threat in resource-poor
settings.
Tuberculosis (TB)
Tuberculosis (TB)

Clinical Scenario A 5-year-old girl is brought to the clinic due to a persistent, nonproductive
cough, low-grade fever, and night sweats lasting for the past 4 weeks. Her parents note she has
lost weight and appears more fatigued than usual. The family recently hosted an uncle who
immigrated from a highly endemic region and was recently diagnosed with a chronic respiratory
illness. Physical examination reveals a discrete, firm, non-tender cervical lymph node mass. A
chest radiograph demonstrates right hilar lymphadenopathy with a focal alveolar infiltrate. A
Tuberculin Skin Test (TST) shows 16 mm of induration. This presentation is classic for primary
pulmonary tuberculosis complicated by scrofula (tuberculous lymphadenitis).

Definition Tuberculosis is a chronic, curable infectious disease caused primarily by

Mycobacterium tuberculosis. The disease exists in three major clinical stages: exposure
(significant contact but negative tests), infection (positive TST/IGRA but no clinical/radiographic
signs), and disease (clinical or radiographic manifestations caused by the multiplying bacilli).

Etiology / Classification The M. tuberculosis complex includes M. tuberculosis, M. bovis, M.

africanum, M. microti, and M. canetti. These tubercle bacilli are non-spore forming, nonmotile,
weakly gram-positive, obligate aerobes. They have a lipid-rich cell wall that renders them "acid-
fast" (resisting decolorization by acid dyes) and protects them from macrophage destruction.

Epidemiology TB is one of the most important infectious diseases worldwide, with almost one-
third of the global population infected. Most cases occur in developing nations (e.g., India,
China, Indonesia). In countries with low general incidence, TB disproportionately affects foreign-
born children, ethnic minorities, homeless individuals, and those with immunodeficiencies,
particularly Human Immunodeficiency Virus (HIV). Multidrug-resistant TB (MDR-TB) is an
increasing global threat.

Pathophysiology Transmission is person-to-person via the inhalation of airborne droplet nuclei,

usually from an adult with cavitary pulmonary TB and a forceful cough. The bacilli enter the
alveoli and are engulfed by macrophages. Some survive intracellularly and are carried to the
regional (usually hilar) lymph nodes, forming the primary (Ghon) complex. Over 2-12 weeks,
cell-mediated immunity and tissue hypersensitivity develop, forming granulomas with central
caseating necrosis that encapsulates the bacilli. If the immune response is weak (as in infants
or immunocompromised patients), the infection can rapidly disseminate.

Clinical Features

● Primary Pulmonary TB: Often asymptomatic, but can present with nonproductive
cough, mild dyspnea, fever, night sweats, and failure to thrive. Large hilar lymph nodes
can compress bronchi, causing localized wheezing or atelectasis.
● Miliary TB (Disseminated): A severe form caused by massive lymphohematogenous
spread. It presents with fever, hepatosplenomegaly, and a classic radiographic pattern of
tiny, evenly distributed "miliary" nodules in the lungs.
● Tuberculous Meningitis: The most serious complication, fatal if untreated. Caused by
the rupture of metastatic caseous lesions (Rich's foci) into the subarachnoid space,
producing a gelatinous exudate that causes hydrocephalus, cranial nerve palsies, and
stroke.
 ● Superficial Lymph Node TB (Scrofula): The most common extrapulmonary form in
children. Presents as firm, discrete, non-tender cervical nodes that may gradually
enlarge, suppurate, and form draining fistulas.
● Skeletal TB: Occurs due to hematogenous spread. The most common form is Pott's
disease (tuberculosis of the spine), leading to the destruction of vertebral bodies, gibbus
deformity, and kyphosis.

Differential Diagnosis For pulmonary disease: Atypical pneumonias (Mycoplasma,

Chlamydophila), deep fungal infections (Histoplasmosis, Blastomycosis, Coccidioidomycosis),
Sarcoidosis, and malignancies (lymphoma). For lymphadenitis (scrofula): Nontuberculous
mycobacteria (NTM), cat-scratch disease (Bartonella henselae), Brucellosis, Toxoplasmosis,
and pyogenic abscesses.

Investigations and Findings

● Screening/Immune Tests:
○ Tuberculin Skin Test (TST / Mantoux): Detects delayed hypersensitivity.
Induration is measured at 48-72 hours. The positivity threshold (≥5
mm, ≥10 mm, or ≥15 mm) depends on the child's risk factors.
○ Interferon-Gamma Release Assays (IGRA): Blood tests (e.g., QuantiFERON-
TB) measuring T-cell release of IFN-$\gamma$. Highly specific because they do
not cross-react with the BCG vaccine or most environmental mycobacteria.
● Imaging: Chest radiograph may reveal hilar lymphadenopathy, a parenchymal primary
focus, pleural effusions, or miliary shadows. CT/MRI of the brain is critical for evaluating
meningitis or tuberculomas.
● Microbiology & Molecular Diagnostics: The gold standard is isolation of M.
tuberculosis via culture from sputum, early morning gastric aspirates (in young children),
or tissue biopsy. Nucleic Acid Amplification Tests (NAAT / Xpert MTB/RIF) offer rapid
detection of the organism and rifampin resistance genes within hours.

Management and Treatment

● Latent Tuberculosis Infection (TBI): Treated to prevent progression to active disease.

Options include 9 months of daily Isoniazid (INH), 4 months of daily Rifampin, or 12
weekly doses of Isoniazid + Rifapentine (3HP) via Directly Observed Therapy (DOT).
● Active Pulmonary TB: Standard therapy is a 6-month regimen: An initial 2-month
intensive phase with 4 drugs (Isoniazid, Rifampin, Pyrazinamide, and Ethambutol),
followed by a 4-month continuation phase with Isoniazid and Rifampin.
● Severe / Extrapulmonary TB: Disseminated disease, bone/joint TB, and CNS
tuberculosis require prolonged treatment for 9-12 months. Corticosteroids (e.g.,
prednisone) are indicated for tuberculous meningitis, pericarditis, and severe miliary TB
to reduce inflammation, intracranial pressure, and long-term sequelae.
● Drug-Resistant TB: Multidrug-resistant TB (MDR-TB) requires individualized regimens
containing second-line agents (e.g., Levofloxacin, Bedaquiline, Linezolid, Amikacin)
under expert consultation for 9-18 months.
● Prevention: The BCG vaccine (a live attenuated strain of M. bovis) is used in highly
endemic areas to limit severe disseminated TB and meningitis in infants, though its
overall efficacy against pulmonary TB varies.

Prognosis With prompt diagnosis and strict adherence to antituberculosis medication, the
prognosis for localized primary pulmonary TB and isolated lymphadenopathy is excellent,
leading to complete cure. However, failure to adhere to therapy can lead to relapse and drug
resistance. Untreated tuberculous meningitis is uniformly fatal, and even with treatment,
advanced-stage CNS disease carries a high risk of permanent neurologic disabilities (blindness,
deafness, hydrocephalus, cognitive impairment).
Fever with a Focus
Fever in the Older Child (Fever with a Focus)
Clinical Scenario A 5-year-old girl presents with a 3-day history of fever up to 39.5°C
(103.1°F). Her mother reports that she has been complaining of pain when urinating, needs to
use the bathroom frequently, and has had two episodes of daytime enuresis (bedwetting) after
previously being fully toilet trained. On examination, the child is febrile and tachycardic but alert.
She exhibits distinct right-sided costovertebral angle tenderness. A urinalysis reveals positive
leukocyte esterase, positive nitrites, and >20 white blood cells per high-power field. This classic
presentation localizes the focus of her fever to the genitourinary tract, confirming an acute
urinary tract infection (pyelonephritis).

Definition Fever is defined as a rectal temperature $\ge$38.0°C (100.4°F). A temperature

>40°C (104°F) is termed hyperpyrexia. Unlike fever in young infants, pediatricians can more
readily rely on specific symptoms and physical examination findings to establish a focal
diagnosis in older children.

Etiology / Classification The causes of fever with a focus in children can be categorized
broadly into viral and bacterial infections, organized by body region:

● Viral Infections (Most Common): Enteroviruses (e.g., coxsackieviruses causing hand-

foot-and-mouth disease), respiratory viruses (RSV, influenza, parainfluenza, SARS-CoV-
2), and gastrointestinal viruses (norovirus, rotavirus).
● Ear, Nose, and Throat (ENT): Acute otitis media, mastoiditis, acute bacterial sinusitis,
streptococcal pharyngitis, viral laryngotracheobronchitis (croup), and epiglottitis.
● Respiratory: Pneumonia (viral, bacterial, or atypical) and bronchiolitis.
● Gastrointestinal / Abdominal: Viral gastroenteritis, bacterial enteritis, appendicitis,
cholecystitis, and hepatitis.
● Genitourinary: Urinary tract infection (UTI), pyelonephritis, pelvic inflammatory disease,
and epididymitis.
● Musculoskeletal: Osteomyelitis and septic arthritis.
● Skin and Soft Tissue: Cellulitis, impetigo, abscess/furuncle, and viral exanthems.
● Central Nervous System: Meningitis (viral/bacterial), encephalitis, and brain abscess.

Pathophysiology Body temperature is regulated by thermosensitive neurons in the

preoptic/anterior hypothalamus. In response to infectious pathogens (exogenous pyrogens),
macrophages and other cells produce endogenous pyrogens (cytokines such as Interleukin-1,
Interleukin-6, Tumor Necrosis Factor-$\alpha$, and Interferons). These cytokines stimulate the
production of prostaglandin E2, which attaches to receptors in the hypothalamus to raise the
body's temperature set point, inducing fever.

Clinical Features A thorough history and physical examination should systematically elicit
symptoms for each body system to localize the focus:

● General: Tachycardia normally accompanies fever, rising by 10 beats/min for every 1°C
(1.8°F) increase in temperature. "Toxic" appearance, hypotension, poor perfusion, or
altered mental status are red flags for septic shock or meningitis.
● Head/Neck: Severe headache, photophobia, or meningismus suggest meningitis. Ear
pain/pulling suggests otitis media; sore throat with exudate suggests pharyngitis.
● Cardiopulmonary: Tachypnea, focal crackles, or hypoxia point to pneumonia.
 ● Abdomen/GU: Vomiting, diarrhea, or abdominal pain can indicate gastroenteritis or
appendicitis. Dysuria, urinary frequency, or back pain strongly point to a UTI.
● Musculoskeletal: Extremity pain, limp, joint swelling, or refusal to bear weight indicate
possible osteoarticular infection (osteomyelitis or septic arthritis).
● Dermatologic: A blanching maculopapular rash often accompanies viral exanthems,
while petechiae or purpura in an ill-appearing child are ominous signs of
meningococcemia, Rocky Mountain spotted fever, or endocarditis.

Investigations and Findings Laboratory and radiographic studies are not routinely indicated
for every febrile child but are selected based on the suspected focus:

● Respiratory Focus: Chest radiography is indicated for patients with respiratory

symptoms, hypoxia, tachypnea, or focal auscultatory findings. Rapid antigen or PCR
testing may be utilized for influenza, RSV, or SARS-CoV-2.
● ENT Focus: Rapid antigen testing and throat culture for group A Streptococcus in cases
of exudative pharyngitis.
● Genitourinary Focus: Urinalysis and urine culture are essential for children with
dysuria, back pain, or those at high risk for occult UTI (e.g., females <1-2 years,
uncircumcised males).
● Severe / Systemic Illness: Children who appear toxic, immunocompromised, or have
unstable vital signs require a complete blood count (CBC), blood cultures, inflammatory
markers (CRP, procalcitonin), and potentially a lumbar puncture (LP).

Management and Treatment

● Supportive Care: Encouraging good hydration is critical to replace fluids lost due to
increased metabolic demands and insensible losses.
● Antipyretics: Treating fever in self-limiting illnesses solely to normalize body
temperature is not necessary. However, to relieve discomfort, acetaminophen (10-15
mg/kg/dose every 4 hours) or ibuprofen (5-10 mg/kg/dose every 8 hours for children >6
months old) are safe and effective. They work by reducing prostaglandin production.
● Targeted Antimicrobial Therapy: Antibiotics are administered when there is a clear
bacterial focus of infection (e.g., amoxicillin for acute otitis media or streptococcal
pharyngitis, targeted therapy for UTI or pneumonia).

Prognosis The prognosis depends entirely on the underlying etiology. Most older infants and
children with fever have benign, self-limited viral infections and recover fully with supportive
care. Prompt identification of a bacterial focus (such as pneumonia or UTI) and initiation of
appropriate antibiotics typically lead to rapid clinical improvement and excellent long-term
outcomes.
Throat Infection &Ear Infection
Throat Infection (Acute Pharyngitis & Tonsillitis)
Clinical Scenario A 7-year-old girl is brought to the clinic in late winter with a sudden onset of
severe sore throat, fever of 39.0°C (102.2°F), headache, and abdominal pain. She has no
cough or runny nose. On examination, her tonsils are erythematous and enlarged with patchy
yellow exudates, and she has tender, enlarged anterior cervical lymph nodes. A Rapid Antigen
Detection Test (RADT) in the office is positive for Group A Streptococcus. She is prescribed a
10-day course of oral amoxicillin to treat the infection and prevent acute rheumatic fever.

Definition Pharyngitis refers to inflammation of the pharynx, characterized by erythema,

edema, exudates, or an enanthem (ulcers or vesicles).

Etiology

● Viruses (Most Common): Viruses predominate as the acute infectious causes of

pharyngitis. Common agents include adenoviruses, coronaviruses (including SARS-
CoV-2), enteroviruses (Coxsackievirus), Epstein-Barr virus (EBV), herpes simplex virus
(HSV), influenza viruses, parainfluenza viruses, respiratory syncytial virus (RSV), and
rhinoviruses.
● Bacteria: Group A Streptococcus (GAS; Streptococcus pyogenes) is the most
important bacterial cause, accounting for 15–30% of pharyngitis in school-age
children. Other bacterial causes include group C and G streptococci, Arcanobacterium
haemolyticum, Fusobacterium necrophorum (especially in adolescents), Neisseria
gonorrhoeae, Mycoplasma pneumoniae, Chlamydophila pneumoniae, and
Corynebacterium diphtheriae.

Epidemiology Acute viral upper respiratory infections occur most commonly in the fall, winter,
and spring. GAS pharyngitis is most prevalent in school-age children (5–15 years old) during the
winter and early spring and is relatively uncommon before 2 to 3 years of age.

Clinical Features

● Viral Pharyngitis: Symptoms usually develop gradually. The presence of conjunctivitis,

coryza (runny nose), cough, diarrhea, hoarseness, discrete ulcerative stomatitis, or a
viral exanthema strongly points to a viral etiology. Oral HSV can cause extensive
ulcerating vesicles on the gums, lips, and anterior pharynx with high fever. Enteroviruses
cause herpangina (vesicles/ulcers on the posterior oropharynx) or hand-foot-and-mouth
disease.
● GAS Pharyngitis: Typically presents with sudden onset of sore throat, fever, headache,
nausea, vomiting, and abdominal pain. Physical signs include tonsillopharyngeal
erythema and exudates, palatal petechiae, a "strawberry tongue," and tender anterior
cervical adenitis. Patients infected with exotoxin-producing strains may develop Scarlet
Fever, characterized by circumoral pallor and a fine, red, papular "sandpaper" rash that
is more intense in skin creases (Pastia lines) and subsequently peels.

Differential Diagnosis It can be challenging to clinically differentiate GAS pharyngitis from viral
pharyngitis, particularly EBV infectious mononucleosis, which also presents with exudative
tonsillitis, but typically includes splenomegaly or generalized lymphadenopathy. Fusobacterium
necrophorum can cause exudative pharyngitis similar to GAS but is uniquely associated with
Lemierre syndrome (internal jugular vein septic thrombophlebitis). Diphtheria presents with a
characteristic gray pseudomembrane and "bull neck" swelling. Noninfectious causes include
Kawasaki disease, PFAPA syndrome, and Stevens-Johnson syndrome.

Investigations and Findings

● Clinical Scoring: The Centor or McIsaac score (points for fever >38°C, absence of
cough, tender anterior cervical adenopathy, tonsillar swelling/exudates, and age 3-14
years) helps identify patients who need testing.
● Rapid Antigen Detection Tests (RADTs): Highly specific (≥95%); a positive test
is assumed accurate and does not require a backup culture. Because of lower
sensitivity, a negative RADT should be confirmed with a throat culture.
● Throat Culture: The gold standard for diagnosing streptococcal pharyngitis.
● Molecular Tests (PCR): Highly sensitive and specific tests that amplify GAS DNA in
less than an hour; they are increasingly replacing throat cultures.

Management and Treatment

● Viral Pharyngitis: Symptomatic therapy is the mainstay, including oral

antipyretics/analgesics (acetaminophen or ibuprofen) to relieve fever and pain.
● GAS Pharyngitis: Early antibiotic therapy hastens clinical recovery and prevents acute
rheumatic fever if started within 10 days. Oral penicillin V or amoxicillin for 10 days is
the drug of choice. A single intramuscular dose of benzathine penicillin G is also
effective. For penicillin-allergic patients, options include first-generation cephalosporins,
clindamycin, or macrolides (erythromycin, azithromycin, clarithromycin).
● Tonsillectomy: May be considered for children with severe recurrent throat infections
defined by the Paradise Criteria: ≥7 episodes in the past year, ≥5 episodes/year
for 2 years, or ≥3 episodes/year for 3 years.

Complications

● Suppurative: Cervical lymphadenitis, peritonsillar abscess, retropharyngeal abscess,

otitis media, and mastoiditis.
● Nonsuppurative (Post-Infectious): Acute Rheumatic Fever (ARF), Acute
Poststreptococcal Glomerulonephritis (APSGN), poststreptococcal reactive arthritis, and
PANDAS (pediatric autoimmune neuropsychiatric disorders associated with
streptococci).

Ear Infection (Otitis Media & Otitis Externa)

Clinical Scenario An 18-month-old boy is brought to the clinic due to fever, irritability, and
crying while pulling at his right ear for the past 24 hours. He recently had a cold with a runny
nose and mild cough. On pneumatic otoscopy, his right tympanic membrane is markedly
bulging, opaque, erythematous, and has poor mobility. Given his age, distinct TM bulging, and
fever, he is diagnosed with confirmed Acute Otitis Media and started on high-dose oral
amoxicillin (80-90 mg/kg/day).
Definition

● Acute Otitis Media (AOM): Inflammation of the middle ear presenting with a rapid onset
of symptoms and signs of acute infection.
● Otitis Media with Effusion (OME): Inflammation accompanied by middle-ear effusion
(MEE) without signs of acute infection.
● Otitis Externa (OE): Inflammation of the skin of the external auditory canal, often
resulting from excessive moisture (swimmer's ear) or trauma.

Etiology

● AOM: The most common bacterial pathogens are Streptococcus pneumoniae,

nontypeable Haemophilus influenzae, and Moraxella catarrhalis. Viral co-pathogens
(RSV, rhinovirus, influenza, adenovirus) are frequently present.
● OE: Predominantly caused by Pseudomonas aeruginosa (up to 60%) and
Staphylococcus aureus. Fungi such as Candida and Aspergillus may also be isolated.

Epidemiology & Risk Factors The peak incidence of OM is during the first 2 years of life. Risk
factors include day care attendance, poverty, crowding, environmental tobacco smoke, and
pacifier use. Breast milk feeding is highly protective against OM. OE is predisposed by
excessive wetness (swimming/bathing), dry canal skin, or mechanical trauma (e.g., from cotton-
tipped swabs).

Pathophysiology AOM is usually precipitated by a viral upper respiratory infection that causes
inflammatory edema and obstruction of the eustachian tube. This leads to negative middle-ear
pressure, accumulation of secretions, and multiplication of bacteria that migrate from the
nasopharynx. In chronic OM, pathogenic biofilms on the middle-ear mucosa and adenoids
contribute to persistence. In OE, maceration from moisture or trauma breaks down the skin
barrier, allowing normal flora or exogenous gram-negative bacteria to invade the tightly adhered
canal skin.

Clinical Features

● AOM: Symptoms include otalgia (ear pain), fever, irritability, or changes in sleep/eating
habits. Infants may simply pull or rub their ears. Examination reveals a bulging, opaque,
often erythematous tympanic membrane (TM) with decreased mobility.
● OME: Often asymptomatic except for mild to moderate conductive hearing loss,
unsteadiness, or a sense of fullness. The TM is usually retracted, opaque or amber-
colored, with decreased mobility and possible air-fluid levels or bubbles.
● OE: Rapid onset of severe ear pain that is markedly accentuated by manipulation of the
pinna or pressure on the tragus. The canal is edematous and erythematous, often with
thick, clumpy, white or greenish purulent otorrhea.

Investigations and Findings

● Pneumatic Otoscopy: The primary tool to assess TM mobility and differentiate

AOM/OME from a normal ear.
● Tympanometry: Provides an objective electroacoustic measure of TM compliance; a
flattened curve (Type B) indicates decreased mobility usually due to middle-ear fluid.
● Tympanocentesis: Aspiration of middle-ear fluid for culture; rarely needed but used for
neonates, immunocompromised children, or patients failing multiple antibiotic courses.
Management and Treatment

● AOM:
○ Pain Management: Acetaminophen or ibuprofen is crucial for otalgia.
○ Observation ("Watchful Waiting"): May be offered for 48-72 hours in
children ≥2 years with non-severe, uncomplicated AOM, provided close
follow-up is ensured.
○ Antibiotics: High-dose Amoxicillin (80-90 mg/kg/day) is the first-line treatment
of choice. For patients who fail initial therapy or have received amoxicillin in the
last 30 days, second-line agents include Amoxicillin-clavulanate, Cefdinir,
Cefpodoxime, or IM Ceftriaxone. Standard duration is 10 days for young/severe
cases, though shorter courses (5-7 days) may suffice for older children.
● OME: Observation is recommended as most cases resolve spontaneously within 3
months. Antibiotics and antihistamines are generally not effective and not
recommended.
● Surgical Management: Myringotomy with tympanostomy tube insertion is considered
for recurrent AOM (3 episodes in 6 months or 4 in 12 months) or OME persisting >3
months with associated hearing loss.
● OE: Requires cleaning of the canal debris and application of topical otic drops
containing an antibiotic (e.g., ciprofloxacin, neomycin, polymyxin) and a corticosteroid
(e.g., hydrocortisone, dexamethasone). If canal edema is severe, a wick may be inserted
to draw the medication inward. Systemic antibiotics are reserved for severe cases with
fever or spread outside the canal.

Complications

● Intratemporal: Acute coalescent mastoiditis (destruction of mastoid air cells,

postauricular swelling/erythema), TM perforation, chronic suppurative otitis media
(CSOM), cholesteatoma, facial nerve palsy, labyrinthitis, and hearing loss.
● Intracranial: Meningitis, epidural/subdural abscess, brain abscess, and lateral/sigmoid
sinus thrombosis.
Measles (Rubeola)
Measles (Rubeola)
Clinical Scenario A 2-year-old unimmunized boy presents with a 4-day history of high fever
(104°F), a harsh barking cough, runny nose (coryza), and red, photophobic eyes (conjunctivitis).
Today, his mother noticed a red, blotchy maculopapular rash that started along his hairline and
behind his ears, which is now spreading down to his trunk. On oral examination, tiny red lesions
with bluish-white centers (Koplik spots) are seen on the buccal mucosa opposite the lower
molars. This presentation is classic for acute measles.

Definition Measles is an acute, highly contagious viral disease characterized by a prodromal

phase of high fever, cough, coryza, and conjunctivitis (the "3 Cs"), followed by a pathognomonic
enanthem (Koplik spots) and a generalized maculopapular exanthem (rash) that erupts
successively over the neck, face, body, arms, and legs.

Etiology Measles is caused by the measles virus, a negative-sense single-stranded, lipid-

enveloped RNA virus belonging to the Paramyxoviridae family and the genus Morbillivirus.
Humans are the only natural host.

Epidemiology Before the introduction of the measles vaccine, the infection was universal in
childhood, with 90% of children acquiring it before age 15. Through extensive vaccination
efforts, endemic transmission was eliminated in the United States in 2000. However, imported
cases continue to cause outbreaks, primarily concentrated among unimmunized or under-
immunized populations. Globally, measles remains a leading cause of vaccine-preventable
death, particularly in resource-poor countries among malnourished children younger than 5
years old.

Pathophysiology Transmission occurs via inhalation of large airborne droplets or small-droplet

aerosols suspended in the air (which can remain infectious for up to 2 hours). The virus infects
the respiratory epithelium, migrates to regional lymph nodes, and initiates a primary viremia that
disseminates the virus to the reticuloendothelial system. A secondary viremia then spreads the
virus to the body surfaces. Measles infection causes necrosis of the respiratory tract epithelium
and induces the formation of multinucleated epidermal syncytial giant cells (Warthin-Finkeldey
giant cells), which are pathognomonic for the disease. The virus also infects CD4+ T cells,
resulting in profound immunosuppression.

Clinical Features

● Incubation: Lasts 8-12 days.

● Prodromal (Catarrhal) Stage: Lasts 3-5 days. Characterized by high fever (up to 104°-
105°F), lassitude, and the classic triad of prominent cough, coryza, and conjunctivitis
with photophobia.
● Koplik Spots (Enanthem): Discrete red lesions with bluish-white centers on the inner
cheeks opposite the premolars/lower molars. They typically appear 1-4 days before the
rash and fade quickly.
● Maculopapular Rash (Exanthem): The rash coincides with an abrupt spike in
temperature. It begins on the forehead, around the hairline, and behind the ears, then
spreads centrifugally downward to the torso and extremities. It often becomes confluent
on the face and upper trunk. After about 7 days, the rash fades in the same downward
progression, often leaving a fine, branny desquamation and brownish discoloration.
 ● Inapparent / Modified Measles: Occurs in individuals with passively acquired antibody
(infants <6 months) or previously vaccinated persons. The rash and symptoms may be
indistinct, brief, or absent, and these patients are not highly contagious.

Differential Diagnosis

● Roseola infantum (Exanthem subitum): Fever subsides when the rash appears,
whereas in measles, the fever peaks with the rash.
● Rubella: The rash is similar but the illness is milder, fever is lower, and prominent
suboccipital/postauricular lymphadenopathy precedes the rash without the severe
prodromal cough.
● Kawasaki Disease: Shares findings like conjunctivitis and rash but lacks Koplik spots
and severe cough; characteristically shows thrombocytosis (measles has
thrombocytopenia).
● Other infections: Infectious mononucleosis, scarlet fever, erythema infectiosum, and
atypical pneumonias.

Investigations and Findings

● Clinical Diagnosis: Usually based on the classic presentation of fever, the "3 Cs," and
Koplik spots.
● Laboratory: A complete blood count (CBC) typically shows a reduced white blood cell
count (leukopenia) with a relative lymphocytosis. Absolute neutropenia may also occur.
● Confirmatory Tests: Detection of measles-specific IgM antibody in serum (appears 1-2
days after rash onset) or viral detection via PCR of nasopharyngeal aspirates, throat
swabs, or urine.

Complications Morbidity and mortality are highest in children <5 years old (especially <1 year),
immunocompromised patients, and those with severe malnutrition (e.g., Vitamin A deficiency).

● Respiratory: Pneumonia is the most common cause of death (either giant cell viral
pneumonia or secondary bacterial infections with S. pneumoniae, H. influenzae, or S.
aureus). Otitis media is the most common complication overall. Croup and bronchiolitis
frequently require airway support.
● Neurologic: Post-infectious encephalitis occurs in 1-3 per 1,000 cases, often resulting in
permanent neurologic sequelae or death. Measles inclusion-body encephalitis
(MIBE) is a highly lethal form seen in immunocompromised hosts.
● Subacute Sclerosing Panencephalitis (SSPE): A rare, chronic, and universally fatal
neurodegenerative disease that manifests 7-10 years after wild-type measles infection. It
is most common in children who acquire primary measles before 2-4 years of age.
● Other: Diarrhea/gastroenteritis, corneal ulceration (exacerbated by Vitamin A deficiency
leading to blindness), myocarditis, and hemorrhagic ("black") measles.

Management and Treatment

● Supportive Care: Maintenance of hydration, oxygenation, antipyretics

(paracetamol/ibuprofen), and airway humidification.
● Vitamin A Therapy: Significantly reduces morbidity and mortality. The WHO
recommends administration once daily for 2 days: 200,000 IU for children $\ge$12
months; 100,000 IU for infants 6-11 months; and 50,000 IU for infants <6 months.
 ● Antiviral Therapy: No specific antiviral is approved, but Ribavirin is sometimes used for
severe measles pneumonia or in severely immunocompromised patients.
● Bacterial Superinfections: Treat complicating pneumonia or otitis media with
appropriate antibiotics.

Prognosis In well-nourished children, it is typically a self-limited disease resolving in 7-10 days.

However, case fatality is high in malnourished populations (up to 10 deaths per 1,000 cases, or
higher in resource-poor areas) and in immunocompromised hosts.

Prevention

● Infection Control: Patients shed the virus from 7 days after exposure until 4-6 days
after the onset of the rash. Airborne and standard precautions must be strictly observed
in healthcare settings.
● Vaccination: The live-attenuated measles vaccine (given as MMR or MMRV) provides
95% protection. In the US, a 2-dose series is recommended at 12-15 months and 4-6
years of age.
● Travel/Outbreaks: Infants 6-11 months old traveling internationally or caught in an
epidemic should receive an early dose of MMR (though this dose is not considered part
of the routine series, and they still require two doses after 12 months of age).
● Post-exposure Prophylaxis:
○ Vaccine: Can prevent or modify the disease if administered within 72 hours of
exposure in immunocompetent individuals.
○ Immune Globulin (IG): Indicated within 6 days of exposure for susceptible
household contacts at high risk, including infants <6 months of age, pregnant
women, and immunocompromised persons
Diphtheria
 Diphtheria
Clinical Scenario A 6-year-old unimmunized boy recently arrived from a refugee camp
presents with a 3-day history of sore throat, malaise, and low-grade fever. He appears toxic and
anxious, with noisy breathing (stridor) and massive swelling of his neck (bull-neck). Examination
of his oropharynx reveals a thick, gray-brown, leather-like membrane covering his tonsils and
extending to the uvula. When the physician attempts to swab the lesion, the membrane remains
firmly adherent and bleeds. This presentation is highly classic for severe respiratory diphtheria.

Definition Diphtheria is an acute, highly contagious toxic infection caused primarily by toxin-
producing strains of Corynebacterium diphtheriae and, less frequently, by toxin-producing
strains of C. ulcerans. It primarily affects the respiratory tract and the skin, leading to local tissue
destruction and severe systemic toxicity.

Etiology Corynebacterium diphtheriae is an aerobic, non-spore forming, pleomorphic, gram-

positive bacillus. There are four biotypes capable of causing the disease: mitis, intermedius,
belfanti, and gravis (with intermedius being the most frequently toxigenic and gravis having the
highest fatality rate). The ability of the bacteria to produce the diphtheria toxin depends entirely
on the acquisition of a lysogenic corynebacteriophage that encodes the toxin gene.

Epidemiology Diphtheria is transmitted person-to-person primarily by respiratory droplets,

direct contact with respiratory secretions, or contact with exudate from infected skin lesions. The
organism exclusively inhabits human mucous membranes and skin, and asymptomatic
respiratory tract carriage plays an important role in transmission. While widespread use of the
diphtheria toxoid vaccine has made it rare in the United States, it remains endemic in
developing nations with poor immunization rates (especially in Southeast Asia and Africa) and is
prone to causing outbreaks in areas of crowding, poverty, and conflict. In the vaccine era, the
disease has shifted to frequently affecting unimmunized or underimmunized adults.

Pathophysiology The bacteria usually remain localized in the superficial layers of the
respiratory mucosa or skin lesions, multiplying and producing a potent polypeptide exotoxin.
This exotoxin is an extremely potent inhibitor of protein synthesis, leading to local hyperemia,
edema, and the destruction of superficial epithelium. This necrotic process forms a dense
coagulum composed of organisms, epithelial cells, fibrin, leukocytes, and erythrocytes—the
characteristic pseudomembrane. The toxin is subsequently absorbed into the systemic
circulation, where it can cause distant toxic injury, most notably demyelination of peripheral
nerves and necrosis of kidney tubules and the myocardium.

Clinical Features The median time from infection to the onset of prodromal symptoms is 1.4
days (range 1-10 days).

● Pharyngeal/Tonsillar Diphtheria: Sore throat is the universal early symptom, though

fever is only present in about half of the patients. A unilateral or bilateral gray-brown
pseudomembrane forms and is tightly adherent; attempts to remove it cause bleeding.
Massive soft tissue edema and enlarged lymph nodes cause a "bull-neck" appearance.
● Laryngeal Diphtheria: Patients present with hoarseness, a brassy cough, increasing
stridor, and signs of severe airway obstruction (subcostal retractions).
● Nasal Diphtheria: Often presents as a mild disease with serosanguineous, purulent
nasal discharge and excoriation of the upper lip, sometimes with a visible white
membrane on the nasal septum.
 ● Cutaneous Diphtheria: Characterized by an indolent, non-healing, punched-out ulcer
with a gray-brown membrane. It is often a secondary infection of a pre-existing wound or
dermatosis.

Differential Diagnosis Pharyngeal diphtheria must be differentiated from acute streptococcal

pharyngitis, infectious mononucleosis (EBV), Vincent angina, Lemierre syndrome, and
infections by Arcanobacterium haemolyticum or Fusobacterium necrophorum. Viral
laryngotracheobronchitis (croup), bacterial epiglottitis, and bacterial tracheitis should be
considered for laryngeal involvement.

Investigations and Findings

● Direct Smear: Gram stain is unreliable for diagnosis.

● Culture: The laboratory must be notified to use selective media (e.g., cystine-tellurite
blood agar, Loffler's medium, or Tinsdale agar). Specimens should be obtained from the
nose, throat, and beneath the membrane.
● Toxigenicity Testing: Demonstration of toxin production is required to confirm the
disease, using the modified Elek test (agar immunoprecipitin) and/or PCR for the toxin
gene.

Complications

● Airway Obstruction: Progression of the pseudomembrane and edema can lead to

sudden, fatal suffocation. Obstruction is responsible for 60-65% of overall deaths.
● Toxic Cardiomyopathy: Occurs in 10-25% of respiratory cases and causes 20-25% of
all deaths. It presents 2-6 weeks after infection with tachycardia, weak pulse, heart
failure, and ECG changes (prolonged PR interval, ST/T wave changes, heart block).
● Toxic Neuropathy: Occurs in 20-25% of untreated cases. Palatal and pharyngeal
paralysis occur early (nasal voice, regurgitation of food), followed later by cranial
neuropathies (oculomotor/ciliary paralysis causing strabismus) and a symmetric
demyelinating polyneuropathy that mimics Guillain-Barré syndrome.

Management and Treatment

● Diphtheria Antitoxin (DAT): This is the most critical therapy and must be given
immediately based on clinical suspicion, without waiting for lab confirmation. Because it
neutralizes only free toxin, any delay diminishes its efficacy. It is given as a single
empirical IV dose (20,000 to 100,000 units depending on severity), and patients must be
tested for hypersensitivity to horse serum prior to administration.
● Antibiotics: Therapy is required to halt toxin production, treat the local infection, and
prevent transmission. Erythromycin (40-50 mg/kg/day PO or IV for 14 days) or Penicillin
G (150,000–250,000 units/kg/day IV or IM for 14 days) are the recommended
treatments. Elimination must be documented by two consecutive negative cultures taken
24 hours apart after stopping antibiotics.
● Supportive Care & Isolation: Strict droplet precautions for respiratory diphtheria and
contact precautions for cutaneous diphtheria. Strict bed rest for 2-3 weeks is essential to
minimize the risk of exacerbating myocarditis. Tracheostomy or intubation should be
performed early if airway compromise is present.

Prognosis The case fatality ratio for untreated, unvaccinated cases is 29%, but improves to
10% with antitoxin treatment. The prognosis depends heavily on the speed of antitoxin
administration, patient age, immunization status, and the virulence of the organism. Recovery
from the disease does not guarantee immunity, so patients must be immunized during
convalescence.

Prevention

● Vaccination: Universal immunization with diphtheria toxoid (given as DTaP, DT, Tdap,
or Td depending on age) is the only effective control measure. While it does not prevent
colonization, it is 87-99% effective in preventing symptomatic disease, prevents toxic
complications, and drastically reduces transmission.
● Management of Contacts: All close contacts should be monitored for 7 days, cultured,
and given antimicrobial prophylaxis (a single dose of IM benzathine penicillin G or a 7-10
day course of oral erythromycin) regardless of their immunization status. Their
vaccination status should also be updated.
● Carriers: Asymptomatic carriers must be treated with 10-14 days of antibiotics and kept
in isolation until three consecutive negative cultures are obtained.
Poliomyelitis (Polio)
Poliomyelitis (Polio)

Clinical Scenario A 4-year-old unimmunized boy in a rural village presents with a sudden onset
of weakness in his right leg. A week prior, he had a brief illness characterized by low-grade
fever, sore throat, nausea, and headache that seemed to resolve. Yesterday, the fever returned,
accompanied by severe muscle pain and neck stiffness. On physical examination, he has
asymmetric flaccid paralysis of his right lower extremity. Deep tendon reflexes in the right leg
are absent, but sensory examination is completely normal. He exhibits the "tripod" and "kiss-the-
knee" signs due to nuchal-spinal rigidity. His clinical presentation is highly suggestive of spinal
paralytic poliomyelitis.

Definition Poliomyelitis is an acute viral infection caused by the poliovirus that ranges from a
mild, asymptomatic infection to a rapidly progressive disease leading to acute flaccid paralysis,
encephalitis, and death.

Etiology Poliovirus is a nonenveloped, positive-stranded RNA enterovirus belonging to the

Picornaviridae family. There are three antigenically distinct serotypes: types 1, 2, and 3.
Humans are the only natural host and reservoir for the virus.

Epidemiology The widespread use of polio vaccines has resulted in a >99% decline in
poliomyelitis cases globally, eliminating wild-type poliovirus from most of the world. Wild
poliovirus type 2 and type 3 have been eradicated, leaving wild poliovirus type 1 endemic only in
Afghanistan and Pakistan. However, circulating vaccine-derived polioviruses (cVDPV), which
emerge when the live attenuated oral vaccine virus mutates after prolonged replication in under-
immunized populations, now cause more cases of paralytic polio than wild-type viruses.
Transmission occurs via the fecal-oral route (and possibly the respiratory route), with the virus
shed in feces for several weeks.

Pathophysiology Polioviruses enter the host via the gastrointestinal tract, binding to the CD155
receptor. Primary viral replication occurs in the epithelial cells and lymphoid tissues of the
tonsils, small intestine, and Peyer patches. This leads to a primary viremia, seeding the
reticuloendothelial system. The virus then accesses the central nervous system (CNS), likely
along peripheral nerves. In the CNS, the virus preferentially infects and destroys motor neurons
in the anterior horn of the spinal cord and the cranial nerve nuclei in the medulla oblongata.
Clinical signs of weakness appear when >50% of the motor neurons supplying a muscle are
destroyed. Infection prompts local mucosal immunity mediated by secretory IgA, which is critical
for defending against subsequent gastrointestinal reinfection.

Clinical Features The incubation period is generally 8–12 days (range: 5–35 days). The clinical
response takes one of several forms:

● Asymptomatic Infection: Occurs in 90–95% of cases and produces no symptoms, but

confers lifelong immunity to the infecting serotype.
● Abortive Poliomyelitis: Occurs in ~5% of patients as a brief, nonspecific febrile illness
(minor illness) featuring malaise, anorexia, nausea, sore throat, and headache. It
resolves completely in 2–3 days without neurologic signs.
● Nonparalytic Poliomyelitis (Aseptic Meningitis): Occurs in ~1% of cases, typically
presenting with a biphasic course. Following the minor illness and a brief symptom-free
 period, patients develop intense headache, vomiting, and stiff neck and back (major
illness). Nuchal-spinal rigidity is hallmarked by the "kiss-the-knee" and "tripod" signs.
Deep tendon reflexes may initially be hyperactive before becoming depressed.
● Paralytic Poliomyelitis: Occurs in ~0.1% of cases. It presents with severe muscle pain,
fever, and the rapid onset of asymmetric flaccid paralysis. Crucially, sensation
remains completely intact. It is divided into three syndromes:
○ Spinal Form: Spotty, asymmetric weakness of the neck, abdomen, trunk,
diaphragm, and extremities (proximal > distal). Deep tendon reflexes are absent.
○ Bulbar Form: Involves motor cranial nerves (IX, X, XII) causing a nasal twang to
the voice, inability to swallow (saliva pooling), vocal cord paralysis, airway
obstruction, and vital center involvement (respiratory/cardiovascular
arrhythmias). The "rope sign" (acute angulation between chin and larynx) may be
present.
○ Polioencephalitis: A rare form involving higher brain centers, presenting with
seizures, coma, and spastic paralysis.
● Postpolio Syndrome: Occurs 30–40 years after recovery in 30–40% of survivors,
characterized by new onset of muscle pain, exacerbation of existing weakness, or new
paralysis.

Differential Diagnosis Polio must be differentiated from other causes of acute flaccid paralysis:

● Guillain-Barré Syndrome (GBS): Paralysis is typically symmetric, sensory changes are

common, and cerebrospinal fluid (CSF) shows high protein without pleocytosis
(albuminocytologic dissociation).
● Nonpolio Enteroviruses: Enterovirus D68 and EV-A71 can cause acute flaccid myelitis
clinically indistinguishable from polio, requiring specific viral testing.
● Transverse Myelitis: Rapid, symmetric paralysis with a distinct sensory level, bladder
dysfunction, and normal CSF.
● Traumatic Neuritis: Associated with gluteal intramuscular injections causing
asymmetric, localized sciatic nerve injury.
● Botulism: Presents with descending flaccid paralysis, ptosis, and poorly reactive pupils
following exposure to neurotoxins (e.g., honey in infants).

Investigations and Findings

● Microbiology (Gold Standard): Viral culture of two stool specimens obtained 24–48
hours apart, ideally within 14 days of paralysis onset. Isolates undergo DNA sequence
analysis to differentiate between wild-type poliovirus and vaccine-derived strains. Virus
can also be cultured from throat swabs.
● Cerebrospinal Fluid (CSF): Reveals an aseptic meningitis profile: mild to moderate
pleocytosis (mostly lymphocytes after the first few days), mildly elevated protein, and
normal glucose. Poliovirus is rarely cultured directly from the CSF.

Management and Treatment There is no specific antiviral treatment for poliomyelitis (though
antivirals like pocapavir and V-7404 are in development). Management is strictly supportive:

● Acute Phase: Strict bed rest in a neutral position (using sandbags or splints) to avoid
contractures and minimize skeletal deformity. Avoid all intramuscular injections and
surgical procedures, as they may provoke progression of the disease.
 ● Respiratory/Bulbar Support: Close observation is critical for impending respiratory
failure. Secretions must be suctioned, and mechanical ventilation or tracheostomy may
be required for paralyzed respiratory muscles or vocal cords.
● Pain and Spasms: Analgesics and hot packs relieve muscle tightness.
● Rehabilitation: Physical therapy and orthopedic care commence as soon as the acute
pain resolves to maximize functional recovery and manage persistent deficits.

Prognosis The mortality rate for paralytic polio varies from 5–10% for spinal involvement, but
can be as high as 60% in severe bulbar poliomyelitis. The progression of paralysis usually halts
once the patient's temperature normalizes. Recovery of muscle function can continue for up to
6–18 months; weakness persisting beyond this period is permanent.

Prevention Vaccination is the only effective method of prevention.

● Oral Poliovirus Vaccine (OPV, Sabin): A live-attenuated vaccine given orally. It is

highly effective at inducing secretory IgA mucosal immunity in the gut, which stops wild-
type transmission. However, it carries a rare risk of vaccine-associated paralytic
poliomyelitis (VAPP) (approx. 1 in 750,000 to 1 in 6 million doses) and can mutate into
cVDPV. The world has shifted from trivalent OPV to bivalent OPV (types 1 and 3) and is
introducing novel OPV (nOPV) strains designed to be genetically stable and less prone
to neurovirulent reversion.
● Inactivated Poliovirus Vaccine (IPV, Salk): A killed virus vaccine given intramuscularly
or subcutaneously. It induces strong systemic IgG immunity without the risk of VAPP.
The United States uses an exclusive IPV schedule (administered at 2, 4, 6–18 months,
and 4–6 years of age). Global eradication efforts mandate that infants in OPV-using
countries receive at least one dose of IPV to maintain immunity against type 2 poliovirus.
Tetanus
Tetanus
(Generalized, Neonatal, Localized, and Cephalic)

Clinical Scenario A 7-day-old infant, born at home in a resource-limited setting to an

unimmunized mother, presents with a 24-hour history of progressive difficulty feeding, inability
to suck, and excessive crying. On examination, the infant appears stiff and rigid to the touch.
The umbilical stump is crusted with dirt and dried blood. Suddenly, a loud noise in the room
triggers a generalized muscular spasm, during which the infant's jaw clamps shut (trismus), the
facial muscles contort into a fixed grin (risus sardonicus), and the back arches severely
(opisthotonos). This classic presentation confirms a diagnosis of neonatal tetanus.

Definition Tetanus is an acute, spastic paralytic illness caused by the potent neurotoxin
(tetanospasmin) produced by Clostridium tetani. It is primarily a toxin-mediated process rather
than an invasive infection, characterized by severe, uncontrolled muscle spasms and rigidity.

Etiology Clostridium tetani is a motile, gram-positive, spore-forming obligate anaerobe. Its

natural habitat worldwide is soil, dust, and the alimentary tracts and feces of animals. The
spores are highly resilient and can survive boiling, while the vegetative cells are susceptible to
heat, disinfectants, and antibiotics.

Epidemiology Tetanus occurs worldwide but is most highly endemic in developing countries,
particularly in South Asia and sub-Saharan Africa, where neonatal and maternal tetanus
account for a massive burden of mortality. In the United States, cases have declined by >95%
since 1947 due to widespread vaccination, with the majority of remaining childhood cases
occurring in unimmunized children whose parents objected to vaccination. Most non-neonatal
cases are associated with traumatic injuries, such as deep puncture wounds from dirty objects
(nails, splinters, glass), animal bites, chronic skin ulcers, or contaminated intramuscular
injections. Tetanus is not transmitted from person to person.

Pathophysiology When C. tetani spores are introduced into an anaerobic environment (such
as necrotic tissue in a deep wound or a contaminated umbilical stump), they germinate into
vegetative cells, multiply, and release the exotoxin tetanospasmin. The toxin binds to the
neuromuscular junction, enters the motor nerve, and undergoes retrograde axonal transport to
the spinal cord. Once in the central nervous system, it blocks the release of inhibitory
neurotransmitters (glycine and $\gamma$-aminobutyric acid [GABA]). This removes the normal
inhibition of antagonistic muscles, resulting in sustained, maximal contraction of opposing
muscle groups and characteristic boardlike rigidity.

Clinical Features The incubation period is typically 2-14 days but can range from 1 to 51 days.

● Generalized Tetanus: The most common form. It typically begins with trismus
(lockjaw), headache, and irritability. As the disease progresses, patients develop a
fixed, distorted facial grimace (risus sardonicus) and extreme hyperextension of the
body (opisthotonos). Spasms are excruciatingly painful and easily triggered by minor
stimuli (light, noise, touch). Crucially, the patient's sensorium remains completely
clear. Severe autonomic dysfunction ("autonomic storm") often develops, causing
tachycardia, arrhythmias, diaphoresis, and labile blood pressure.
 ● Neonatal Tetanus: Usually manifests 3-12 days after birth with progressive difficulty
feeding, stiffness, and severe spasms, often localized around a contaminated umbilical
stump.
● Localized and Cephalic Tetanus: Localized tetanus involves painful spasms restricted
to muscles near the injury site. Cephalic tetanus is a rare variant involving bulbar
musculature and cranial nerves (often cranial nerve VII) following head/face wounds or
chronic otitis media.

Differential Diagnosis The dramatic presentation of generalized tetanus is rarely mistaken for
other diseases, but localized symptoms must be differentiated. Trismus may mimic
parapharyngeal, retropharyngeal, or dental abscesses. Rabies can also follow an animal bite
but is distinguished by hydrophobia, predominantly clonic (rather than tonic) seizures, and CSF
pleocytosis. Strychnine poisoning mimics the spasms but typically lacks trismus and features
complete relaxation between spasms. Hypocalcemia produces tetany (carpopedal spasms) but
lacks trismus.

Investigations and Findings

● Clinical Diagnosis: Diagnosis is primarily based on clinical presentation and

immunization history.
● Laboratory Tests: Routine blood counts and cerebrospinal fluid (CSF) analyses are
characteristically normal. Muscle enzymes (CK, aldolase) may be elevated due to
spasms.
● Microbiology: C. tetani is isolated by wound culture in only ~30% of cases and is not
always visible on Gram stain.
● Spatula Test: A simple, highly sensitive and specific bedside test. Touching the
oropharynx with a tongue blade normally elicits a gag reflex; in tetanus, it provokes a
reflex spasm of the masseters, causing the patient to bite down on the spatula.

Management and Treatment

● Supportive Care: Patients must be placed in a dark, quiet, secluded environment

(typically the ICU) to minimize stimuli that provoke spasms. Early endotracheal
intubation or tracheostomy is often required to secure the airway before severe
laryngospasm occurs.
● Toxin Neutralization: Human Tetanus Immune Globulin (TIG) is critical and should
be administered immediately to neutralize circulating toxin before it enters the CNS. The
standard dose is 500 units administered intramuscularly. (Intravenous immune globulin
[IVIG] can be used if TIG is unavailable).
● Antimicrobial Therapy: Metronidazole (intravenous or oral) is currently considered the
antibiotic of choice to eradicate vegetative C. tetani organisms, given for 7-10 days.
Penicillin G is an acceptable alternative.
● Wound Care: Prompt surgical wound excision and debridement are required to remove
anaerobic tissue (though excision of the umbilical stump in neonates is no longer
recommended).
● Control of Spasms and Autonomic Instability: Muscle relaxants are mandatory.
Diazepam is frequently used for relaxation and seizure control. Magnesium sulfate is
utilized to help control autonomic dysfunction. Neuromuscular blocking agents (e.g.,
vecuronium) with mechanical ventilation may be required for severe, refractory cases.
Complications Severe spasms can cause airway obstruction, asphyxiation, aspiration
pneumonia, intramuscular hematomas, rhabdomyolysis, and even fractures of the spine and
long bones. Prolonged immobility and intensive care lead to risks of deep venous thrombosis,
pulmonary embolism, decubitus ulcers, and paralytic ileus. Autonomic storm can cause fatal
cardiac arrhythmias and sudden cardiac arrest.

Prognosis Tetanus has a high mortality rate, particularly in the very young and very old. Case
fatality rates for generalized tetanus range from 5-35%, while neonatal tetanus mortality can
exceed 75% without intensive care. A short incubation period (<7 days) and rapid progression
to generalized spasms (<3 days from onset of trismus) indicate a poor prognosis. Notably, the
minute amount of toxin required to cause disease does not stimulate natural immunity; patients
must be actively immunized during convalescence.

Prevention

● Routine Vaccination: Active immunization with tetanus toxoid (DTaP in infants/children,

Tdap/Td in adolescents and adults) is highly effective.
● Maternal Immunization: Administration of Tdap to pregnant women (preferably at 27-
36 weeks gestation) provides transplacental antibodies that prevent neonatal tetanus.
● Clean Delivery: Proper hygienic practices during childbirth and sanitary umbilical cord
care are vital.
● Wound Management: Thorough irrigation and debridement of injuries are essential.
Post-exposure prophylaxis depends on the wound type and the patient's vaccination
history (see Flow Chart).
Fever Without a Focus
Fever Without a Focus
(in Neonates, Young Infants, and Older Children)

Clinical Scenario A 6-week-old (42 days) previously healthy infant is brought to the clinic with a
rectal temperature of 38.3°C (101°F). The infant is well-appearing, has an uncomplicated
medical history, and the physical examination reveals no localizing source for the fever. To
determine the risk of a serious bacterial infection, laboratory studies including a urinalysis and
inflammatory markers (procalcitonin, C-reactive protein, and absolute neutrophil count) are
obtained. The markers are completely normal, and the urinalysis is negative for leukocyte
esterase and nitrites with $\le$5 WBC/hpf. Given that the child fulfills all low-risk criteria, the
infant is managed with close observation and follow-up in 12-24 hours, without the immediate
need for a lumbar puncture or parenteral antibiotics.

Definition Fever without a focus in neonates and young infants (0-3 months) refers to a rectal
temperature of 38°C (100.4°F) or greater without other presenting signs or symptoms. In older
children, fever without a focus is defined as a fever where the source has not yet been
identified; it is differentiated from Fever of Unknown Origin (FUO) by its shorter duration, as
FUO requires >8 days of evaluation without an identified cause. A temperature exceeding 40°C
(104°F) is termed hyperpyrexia.

Etiology The causes of acute fever are primarily infectious:

● Viral Infections (Most Common): Self-limited viral infections, including enteroviruses

(e.g., coxsackieviruses), respiratory viruses (RSV, influenza, SARS-CoV-2), and
gastrointestinal viruses (norovirus, rotavirus), are the most frequent causes.
● Bacterial Infections: Uncomplicated bacterial infections include otitis media,
pharyngitis, and sinusitis. In neonates and young infants, serious bacterial infections can
involve organisms such as Escherichia coli, Group B Streptococcus, Staphylococcus
aureus, Salmonella species, and Neisseria meningitidis.
● Occult Infections: Urinary tract infection (UTI) is a leading consideration for occult
bacterial infection. Occult pneumococcal bacteremia is rare in fully immunized children
but remains a higher risk in unimmunized or underimmunized children <2 years old.
● Inflammatory Conditions: Conditions such as Kawasaki disease, multisystem
inflammatory syndrome in children (MIS-C), and juvenile idiopathic arthritis should be
considered, particularly among children with prolonged fever.

Pathophysiology Body temperature is regulated by thermosensitive neurons located in the

preoptic or anterior hypothalamus that respond to changes in blood temperature, as well as by
cold and warm receptors located in the skin and muscles. Thermoregulatory responses to raise
or lower temperature include redirecting blood to or from cutaneous vascular beds, increasing or
decreasing sweating, altering extracellular fluid volume via arginine vasopressin, and utilizing
behavioral responses. Fever occurs when the hypothalamic temperature set-point is raised.
Conversely, hyperthermia can occur when heat production exceeds heat loss (e.g., salicylate
poisoning, malignant hyperthermia) or when there is defective heat loss.

Clinical Features

● Neonates & Young Infants: Distinguishing between a serious bacterial infection and a
self-limited viral illness can be exceptionally challenging. Infants may appear completely
 well despite harboring a serious infection, or they may manifest subtle signs such as
lethargy, irritability, poor feeding, abnormal skin findings (rash, petechiae, cyanosis), or
paradoxical irritability (pain during attempts to comfort the child).
● Older Children: Tachycardia normally accompanies fever, rising by 10 beats/min for
every 1°C (1.8°F) increase in temperature in children >2 months old. Relative
bradycardia (temperature-pulse dissociation) is an important clinical clue that may point
to specific infections like typhoid fever, leptospirosis, or drug fever. Petechiae in an ill-
appearing child strongly indicate the possibility of life-threatening conditions such as
meningococcemia or Rocky Mountain spotted fever.

Investigations and Findings Diagnostic evaluation is heavily guided by the patient's age and
overall appearance:

● Neonates (0-28 days): All febrile neonates require hospitalization, complete cultures
(blood, urine, cerebrospinal fluid [CSF]), and the initiation of parenteral antibiotics.
● Young Infants (29-60 days): Evaluated using a stepwise risk stratification process. Low
risk is defined as having an uncomplicated medical history, well-appearing physical
exam, normal urinalysis (negative leukocyte esterase/nitrite, $\le$5 WBC/hpf), and
normal inflammatory markers (temperature $\le$38.5°C, procalcitonin $\le$0.5 ng/mL,
CRP $\le$20 mg/L, absolute neutrophil count $\le$4,000-5,200/mm$^3$). Low-risk
infants may be closely observed without routine lumbar puncture.
● Older Children (2-36 months): In fully immunized, well-appearing children with a
temperature >39°C (102.2°F), routine blood tests (CBC, blood culture) are generally not
indicated because of the low risk of occult bacteremia. However, urine studies (WBC,
leukocyte esterase, nitrite, and culture) are highly recommended to screen for UTI in all
females <12-24 months, uncircumcised males <2 years, and children with recurrent
UTIs. Unimmunized or underimmunized children require a CBC and blood culture to
evaluate for occult bacteremia.
● Viral Testing: Routine viral testing is not generally indicated for mild symptoms but may
be useful in patients with prolonged fever to identify a viral source (e.g., influenza,
SARS-CoV-2) and avoid extensive evaluation for inflammatory conditions.

Management and Treatment

● Supportive Care: Encouraging good hydration is critical to replace fluids lost due to
increased metabolic demands and insensible losses. Treating fever in self-limiting
illnesses solely to normalize body temperature is not necessary. However, to relieve
discomfort, acetaminophen (10-15 mg/kg/dose every 4 hours) or ibuprofen (5-10
mg/kg/dose every 8 hours for children >6 months old) are safe and effective. Aspirin is
strictly contraindicated due to the risk of Reye syndrome. Physical cooling measures
(like tepid baths) are not considered effective for reducing fever.
● Antimicrobial Therapy:
○ Neonates and Toxic-Appearing Children: Require immediate hospitalization
and empirical parenteral antibiotics.
○ Infants 29-60 Days: If inflammatory markers are abnormal, a lumbar puncture
should be performed, and parenteral antimicrobials are administered in the
hospital. If only the urinalysis is abnormal with normal inflammatory markers, oral
antimicrobials may be administered with close home observation.
○ Older Children: Antibiotics are prescribed only if a specific bacterial focus (e.g.,
UTI, pneumonia) is identified or strongly suspected.
Prognosis The vast majority of well-appearing neonates and young infants with fever recover
completely. When serious outcomes do occur in young infants, most infection-related mortality
and long-term morbidity are the result of herpes simplex virus (HSV) infection and bacterial
meningitis.
Malaria
Malaria
Clinical Scenario A 5-year-old girl is brought to the emergency department with a 3-day history
of high-grade fever (104.5°F), chills, severe headache, fatigue, and recurrent episodes of
vomiting. She recently returned from a 1-month family trip to Nigeria and did not take
antimalarial chemoprophylaxis. On physical examination, she appears pale and lethargic, with
marked splenomegaly and mild scleral icterus. A rapid immunochromatographic diagnostic test
is positive for Plasmodium falciparum histidine-rich protein 2 (HRP2), and a Giemsa-stained thin
blood smear reveals numerous erythrocytes infected with signet-ring trophozoites, confirming a
high-density parasitemia. She is admitted to the pediatric intensive care unit and immediately
started on intravenous artesunate for severe malaria.

Definition Malaria is an acute, life-threatening vector-borne illness caused by intraerythrocytic

protozoa of the genus Plasmodium. The disease is classically characterized by paroxysms of
high fever, chills, sweats, fatigue, anemia, and splenomegaly.

Etiology Five species of Plasmodium are known to cause malaria in humans:

1. ** P. falciparum:** The most virulent species, responsible for the vast majority of severe
complications and deaths.
2. ** P. vivax:** The most common species globally outside of Africa.
3. ** P. ovale:** The least common species, transmitted primarily in Africa.
4. ** P. malariae:** Causes the mildest and most chronic form of the infection.
5. ** P. knowlesi:** A primate malaria species that can infect humans, documented
primarily in Southeast Asia (Malaysia, Indonesia, Philippines). Malaria is naturally
transmitted via the bite of an infective female Anopheles mosquito, but it can also be
transmitted through blood transfusions, contaminated needles, or transplacentally
(congenital malaria).

Epidemiology Malaria is a massive global health burden, occurring in 87 countries and causing
an estimated 229 million cases and 409,000 deaths in 2019. The infection predominantly affects
regions in Africa, Asia, and South America. Africa bears the greatest burden, accounting for
94% of all malaria deaths and over 99% of its cases are caused by P. falciparum. Mortality
is concentrated heavily in children under 5 years of age. In the United States, roughly 1,500 to
2,000 imported cases are reported annually, primarily among travelers visiting friends and
relatives in endemic areas without adequate chemoprophylaxis.

Pathophysiology The Plasmodium life cycle in humans involves a massive two-step

amplification process:

● Pre-erythrocytic (Hepatic) Phase: Sporozoites injected by the mosquito quickly enter

hepatocytes, where they multiply asexually to form schizonts. After 1-2 weeks, the
schizonts rupture, releasing thousands of merozoites into the bloodstream. Notably, P.
vivax and P. ovale can form dormant liver stages called hypnozoites, which may
reactivate months or years later to cause disease relapse.
● Erythrocytic Phase: Merozoites invade red blood cells (RBCs) and transform into
trophozoites (ring forms), which multiply into schizonts and eventually rupture the RBCs,
causing the characteristic fever.
● P. falciparum Virulence: This species infects erythrocytes of all ages, leading to
remarkably high parasitemia (up to 60%). Infected erythrocytes develop surface knobs
 that mediate cytoadherence to the vascular endothelium, obstructing capillary blood
flow. This microvascular sequestration leads to tissue hypoxia, metabolic acidosis, and
multi-organ failure (e.g., cerebral edema).

Clinical Features The incubation period varies by species: 9-14 days for P. falciparum and up
to 18-40 days for P. malariae.

● Uncomplicated Malaria: Often begins with a prodrome of headache, fatigue, myalgias,

and nausea. Classic malarial paroxysms consist of chills, followed by high fever (often
>104°F) and profuse diaphoresis, occurring every 48 hours (P. vivax, P. ovale) or 72
hours (P. malariae). However, children frequently lack this classic periodicity and present
with continuous fever, drowsiness, anorexia, vomiting, diarrhea, pallor, and
splenomegaly.
● Severe Malaria (primarily P. falciparum): Defined by specific WHO criteria indicating
life-threatening complications, including:
○ Cerebral Malaria: Impaired consciousness, prolonged coma, or multiple
convulsions.
○ Severe Malarial Anemia: Hemoglobin $\le$5 g/dL in children, resulting from
hemolysis, splenic sequestration, and bone marrow suppression.
○ Respiratory Distress: Deep acidotic breathing resulting from severe metabolic
acidosis (lactate $\ge$5 mmol/L).
○ Other Red Flags: Hypoglycemia (<40 mg/dL), acute kidney injury, jaundice,
circulatory collapse (algid malaria), and prostration.

Differential Diagnosis The differential diagnosis for a febrile traveler returning from an endemic
area is broad and includes dengue fever, typhoid fever (enteric fever), sepsis, pneumonia,
meningitis, encephalitis, leptospirosis, viral hemorrhagic fevers, babesiosis, and brucellosis.

Investigations and Findings

● Microscopy (Gold Standard): Giemsa-stained thick and thin peripheral blood smears.
The thick smear provides highly sensitive detection of parasitemia, while the thin smear
allows for speciation and quantification of the parasite density. Smears should be
repeated every 12-24 hours for three total samples if initially negative but suspicion
remains high.
● Rapid Diagnostic Tests (RDTs): Immunochromatographic assays like BinaxNOW
detect specific antigens (HRP2 for P. falciparum and aldolase for all human species).
They are highly sensitive for P. falciparum (>94%) and P. vivax, providing results in 15
minutes.
● PCR: Highly sensitive and capable of identifying mixed infections, though results are
usually not available rapidly enough for acute management.
● Laboratory Abnormalities: Anemia, thrombocytopenia, normal or slightly elevated
leukocytes, hypoglycemia, and elevated transaminases.

Complications Severe malaria is a medical emergency. Cerebral edema leading to increased

intracranial pressure is a primary cause of death in cerebral malaria. Survivors face a 25% risk
of long-term cognitive impairment, epilepsy, and behavioral problems. Blackwater fever (dark
urine syndrome) is a severe form of acute kidney injury from massive intravascular hemolysis.
Hyperreactive malarial splenomegaly (HMS) is a chronic complication characterized by
massive, persistent splenic enlargement and elevated IgM levels in endemic populations.
Management and Treatment Treatment algorithms depend strictly on the infecting species,
clinical severity, and geographic patterns of drug resistance.

● Severe Malaria (All Species): Must be managed in an intensive care unit (ICU).
Intravenous (IV) Artesunate is the FDA-approved treatment of choice and dramatically
reduces mortality. It is administered at 0, 12, and 24 hours. Once the patient can tolerate
oral medications and parasitemia is <1%, a full follow-on course of an oral Artemisinin
Combination Therapy (ACT) like artemether-lumefantrine must be administered.
● Uncomplicated Chloroquine-Resistant P. falciparum: Options include Artemether-
lumefantrine (Coartem) (preferred), Atovaquone-proguanil (Malarone), or Quinine
sulfate combined with doxycycline or clindamycin.
● Uncomplicated P. vivax and P. ovale: Treated with Chloroquine or
hydroxychloroquine (unless acquired in highly resistant regions like Papua New Guinea
or Indonesia, which require ACTs). Crucially, this must be followed by Primaquine or
Tafenoquine (anti-relapse therapy) for 14 days to eradicate liver hypnozoites.
Quantitative G6PD testing must be performed prior to using primaquine/tafenoquine to
prevent severe hemolytic anemia.
● Supportive Care: Prompt management of hypoglycemia with IV dextrose, seizures with
benzodiazepines, and severe anemia with packed RBC transfusions.

Prognosis In uncomplicated cases treated promptly, defervescence and recovery occur rapidly
within a few days. For severe P. falciparum malaria, the risk of death is highest within the first
24 hours of presentation. Case fatality rates for cerebral malaria range from 15-40%, and overall
mortality correlates heavily with the degree of metabolic acidosis, coma, and acute kidney
injury.

Prevention

● Personal Protection: Use of insect repellents containing DEET (25-35%) or picaridin,

protective clothing, and sleeping under permethrin-impregnated bed nets.
● Chemoprophylaxis for Travelers: Must be initiated before travel to endemic zones.
Options for chloroquine-resistant areas include Atovaquone-proguanil (daily),
Doxycycline (daily, for children >8 years), or Mefloquine (weekly).
● Vaccines: The RTS,S/AS01 and R21/Matrix-M vaccines have been approved by the
WHO for children <2 years of age in moderate-to-high transmission regions, showing a
30% reduction in severe malaria cases.
Typhoid (Enteric) Fever
Typhoid (Enteric) Fever
Clinical Scenario A 7-year-old girl, who recently traveled to a rural village in South Asia with
her family, presents with a 10-day history of continuous high-grade fever, headache, anorexia,
and abdominal pain. She initially had diarrhea but has recently been constipated. On
examination, she appears highly toxic and lethargic, with a furred tongue and a palpably
enlarged liver and soft spleen. Several small (2–4 mm), slightly raised, erythematous
maculopapular lesions that blanch on pressure are noted in a crop on her lower chest and upper
abdomen. Blood tests reveal leukopenia, and a blood culture grows Salmonella Typhi.
Antimicrobial susceptibility testing reveals an Extensively Drug-Resistant (XDR) strain, and she
is admitted for treatment with intravenous meropenem and oral azithromycin.

Definition Typhoid fever is a severe, systemic bacterial infection characterized by prolonged

continuous fever, abdominal pain, delirium, rose spots, and hepatosplenomegaly, which can be
complicated by intestinal bleeding and perforation. Together with paratyphoid fever, it is broadly
referred to as enteric fever.

Etiology Typhoid fever is caused by Salmonella Typhi, while paratyphoid fever is caused by
Salmonella Paratyphi A, B (S. scottmuelleri), and C (S. hirschfeldii). These are gram-negative
bacilli that possess Somatic (O) and Flagellar (H) antigens, as well as a Capsular
polysaccharide virulence (Vi) antigen that interferes with phagocytosis and innate immune
responses. Unlike most nontyphoidal Salmonella species which infect multiple hosts, S. Typhi
and S. Paratyphi are strictly restricted to humans.

Epidemiology Typhoid fever remains a massive global health burden, with an estimated 14.3
million cases globally in 2017. It is highly endemic in developing nations across South and
Southeast Asia, Africa, and Latin America. Infection is transmitted via the fecal-oral route
through ingestion of contaminated food, milk, or water, or by direct contact with an infected
human (acutely ill or a chronic carrier). The highest incidence occurs in school-age children and
young adults, with rates peaking in the 5- to 9-year-old age group.

Pathophysiology Infection requires the ingestion of approximately $10^5$ to $10^9$ viable

organisms to overcome gastric acidity. The bacteria enter the small intestine, penetrate the
mucosa via M cells, and enter the mononuclear phagocytes of the ileal Peyer's patches and
mesenteric lymph nodes. Necrosis of the Peyer's patches causes sloughing of the overlying
epithelium, leading to ulcers that can bleed or perforate. The organisms then pass via the
intestinal lymphatics into the bloodstream (primary bacteremia), disseminating to seed the
reticuloendothelial system (liver, spleen, bone marrow, and gallbladder), where they replicate
intracellularly within macrophages. A secondary bacteremia subsequently occurs, coinciding
with the onset of clinical symptoms and marking the end of the incubation period. Prolonged
fever and toxicity are driven by circulating endotoxins and cytokine production by macrophages.
S. Typhi also produces a unique typhoid toxin that induces cellular DNA breaks, cell cycle
arrest, and cell death.

Clinical Features The incubation period is usually 7–14 days (range 3–30 days). Presentation
varies by age:

● Infants: May present with mild gastroenteritis or severe sepsis, accompanied by

vomiting, diarrhea, abdominal distension, high continuous fever, weight loss, jaundice,
and hepatosplenomegaly.
 ● Older Children: Classically present with high-grade continuous fever, severe headache,
malaise, anorexia, myalgia, and abdominal pain/tenderness. The child often has an
extremely toxic look with a long drawn face and a central furred tongue. While relative
bradycardia (temperature-pulse dissociation) is classic in adults, it is not commonly seen
in children.
● Rose Spots: Seen in roughly 25% of patients, these are 1–5 mm blanching
maculopapular rashes appearing in crops on the upper abdomen and lower chest
around the 7th–10th day, lasting for 2–3 days.
● Gastrointestinal: Diarrhea may occur early, but constipation is also common. The
spleen becomes soft and palpable during the second week of illness.

Differential Diagnosis The differential diagnosis includes gastroenteritis, bronchopneumonia,

sepsis, malaria, tuberculosis, acute hepatitis, amebic liver abscess, shigellosis, brucellosis,
leptospirosis, bacterial endocarditis, infectious mononucleosis, dengue fever, and rickettsial
diseases.

Investigations and Findings

● Cultures (Gold Standard): Blood culture is positive early in 40–60% of cases but may
require serial high-volume draws. Bone marrow culture is the most sensitive
procedure (85–90% positive) and often remains positive despite prior antibiotic therapy.
Urine and stool cultures may become positive in the later stages. Punch biopsies of rose
spots yield Salmonella in 60% of cases.
● Molecular Testing: Polymerase Chain Reaction (PCR) on blood amplifies specific S.
typhi genes within hours and is more specific/sensitive than blood culture.
● Serology (Widal Test): Measures antibody responses to somatic (O) and flagellar (H)
antigens; an "O" titer > 1:160 is suggestive, but the test is unreliable due to frequent
false-positive and false-negative results.
● Laboratory Abnormalities: Complete blood count may uniquely show leucopenia with
relative lymphocytosis despite high fever, though younger children may have
leukocytosis. Normochromic normocytic anemia, thrombocytopenia, and deranged liver
function tests are common.

Complications

● Gastrointestinal (3rd week): Intestinal perforation (0.5–3.0%, usually in the distal

ileum) causing rigid abdomen/peritonitis, and intestinal hemorrhage (1–10%) presenting
with melena or a sudden drop in blood pressure.
● Neurologic/Toxic: Toxic encephalopathy (delirium, muttering, stupor, coma, psychosis),
acute cerebellar ataxia, aphasia, and deafness.
● Cardiovascular: Toxic myocarditis with arrhythmias and cardiogenic shock is a major
cause of death.
● Other Focal Infections: Osteomyelitis, meningitis, pneumonia, pyelonephritis,
endocarditis, septic arthritis, and fatal bone marrow suppression.

Management and Treatment Antibiotic resistance is highly heterogeneous and dynamic;

therefore, antimicrobial susceptibility testing is essential for guiding definitive therapy.

● Uncomplicated Typhoid (Fully Sensitive): Options include oral Fluoroquinolones (e.g.,

Ciprofloxacin, Ofloxacillin for 10-14 days), Azithromycin (for 7 days), Cefixime (for 7-14
days), Chloramphenicol, or Amoxicillin.
 ● Multidrug-Resistant (MDR) Typhoid: Defined as resistance to the historic first-line
drugs (ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol). Treated with
Fluoroquinolones, Azithromycin, or 3rd-generation cephalosporins (Ceftriaxone,
Cefixime).
● Extensively Drug-Resistant (XDR) Typhoid: Resistant to historic first-line drugs plus
fluoroquinolones and 3rd-generation cephalosporins. XDR strains require empirical
therapy with a carbapenem (e.g., meropenem), azithromycin, or a combination of
both.
● Severe/Complicated Typhoid: Requires parenteral antibiotics (e.g., Ceftriaxone,
Cefotaxime, Fluoroquinolones, or Carbapenems if XDR is suspected) for 10-14 days.
Corticosteroids (e.g., dexamethasone 3 mg/kg initially, then 1 mg/kg every 6 hours for
48 hours) significantly improve survival in patients presenting with severe toxemia,
shock, or coma.
● Supportive Care: Blood transfusions for severe bleeding/anemia and surgical
intervention for intestinal perforation with broad-spectrum antibiotic cover.
● Chronic Carriers: Eradication requires high-dose Amoxicillin, TMP-SMX, Ciprofloxacin,
or prolonged therapies, occasionally necessitating cholecystectomy.

Prognosis With appropriate and rapid antibiotic therapy, most children become afebrile within 7
days, and the prognosis is excellent. Delay in treatment, malnutrition, and highly resistant
strains increase the risk of severe complications and mortality. Relapse may occur in 4–8% of
treated patients (usually milder) about 2 weeks after stopping antibiotics. Chronic carriage
occurs in 1–5% of patients.

Prevention

● Sanitation: Improved personal hygiene, hand-washing, provision of clean water, proper

sewage disposal, and boiling/cooking foods thoroughly.
● Vaccination:
○ Live-attenuated Oral Vaccine (Ty21a): Given as 4 doses every other day;
approved for children $\ge$6 years old, with boosters every 5 years.
○ Vi Capsular Polysaccharide Vaccine (ViCPS): Given as a single intramuscular
injection; approved for children $\ge$2 years old, with boosters every 2-3 years.
○ Typhoid Conjugate Vaccine (TCV): Recommended by the WHO for infants and
children $\ge$6 months; provides a T-cell–dependent response and is highly
effective (up to 97% against XDR S. Typhi).
HIV
Human Immunodeficiency Virus (HIV) and Acquired
Immunodeficiency Syndrome (AIDS)
Clinical Scenario A 4-week-old infant is brought to the clinic for a routine evaluation. The
mother had no prenatal care and presented to the emergency department in active labor. At that
time, a rapid HIV antigen/antibody test was positive, and she was started on intravenous
zidovudine. The infant was delivered vaginally and promptly started on a presumptive HIV
therapy regimen of zidovudine, lamivudine, and nevirapine. Today, the infant's HIV DNA PCR
test from birth returns positive, and a repeat PCR test drawn today also returns positive,
confirming in utero/peripartum HIV-1 infection. The infant is transitioned from prophylaxis to full
cART, and trimethoprim-sulfamethoxazole (TMP-SMX) is initiated to prevent Pneumocystis
jirovecii pneumonia.

Definition and Etiology HIV-1 and HIV-2 are single-stranded RNA retroviruses belonging to
the Lentivirus genus. The virus selectively binds to host cells expressing CD4 molecules,
primarily helper T lymphocytes (CD4+ T cells) and macrophages. Entry requires binding to the
CD4 receptor and a chemokine co-receptor (typically CCR5 or CXCR4). Once inside, the viral
enzyme reverse transcriptase creates a double-stranded DNA copy of the viral RNA, which is
then integrated into the host's chromosomal DNA (provirus) by the viral integrase enzyme. This
provirus establishes a latent reservoir that makes eradication of the virus extremely difficult.

Epidemiology Globally, an estimated 2.6 million children under 19 years old live with HIV, with
the vast majority residing in sub-Saharan Africa. The primary route of infection in children under
15 years old is vertical transmission. In the United States, vertical transmission has declined
by >95% to fewer than 100 cases annually due to the success of prenatal screening and cART.
However, adolescents (13–24 years) account for 21% of new HIV infections in the US,
predominantly driven by sexual transmission among young males who have sex with males
(MSM) and heterosexual adolescent females.

Pathophysiology HIV infection disrupts immune homeostasis by progressively depleting CD4+

T-lymphocytes through mechanisms like single-cell killing, syncytia formation, apoptosis, and
immune activation. In untreated children, disease progression generally follows one of three
patterns:

1. Rapid Progression (15-25%): Median survival of 6-9 months if untreated, typically

resulting from in utero infection during rapid fetal CD4 expansion.
2. Slower Progression (60-80%): Median survival of 6 years untreated, typical of
intrapartum infections.
3. Long-Term Survivors (<5%): Minimal progression with relatively normal CD4 counts for
>8 years.

Clinical Features Initial symptoms in infants may be nonspecific, such as persistent

generalized lymphadenopathy, hepatosplenomegaly, failure to thrive, chronic diarrhea, and
severe oral thrush.

● Infections: HIV-infected children commonly experience severe recurrent bacterial

infections (e.g., Streptococcus pneumoniae, Salmonella), bacteremia, and pneumonia.
● Opportunistic Infections: Severe CD4 depletion puts patients at risk for opportunistic
infections, most notably Pneumocystis jirovecii pneumonia (PJP), which peaks at 3-6
 months of age. Other risks include disseminated Mycobacterium avium-intracellulare
complex (MAC), cytomegalovirus (CMV), Cryptosporidium, and Toxoplasma gondii.
● Organ-Specific Disease: Lymphocytic interstitial pneumonitis (LIP) is a chronic diffuse
reticulonodular pulmonary process often linked to Epstein-Barr virus. HIV
encephalopathy can cause progressive neurologic deterioration. HIV-associated
nephropathy (classic focal segmental glomerulosclerosis) and cardiomyopathy can also
occur.

Investigations and Findings

● Infants (<18-24 months): Because maternal IgG crosses the placenta, all HIV-exposed
infants test antibody-positive at birth. Therefore, HIV DNA or RNA PCR (virologic
assays) must be used. Testing is recommended at birth (for high-risk infants), 2-4
weeks, 4-8 weeks, and 4-6 months of age. A positive test must be confirmed by a
second sample.
● Older Children and Adolescents: Diagnosed using a 4th-generation HIV
antigen/antibody combination assay (detects p24 antigen and IgG/IgM antibodies). If
acute infection is suspected and antibodies are negative but p24 is positive, HIV RNA
PCR is used to confirm.
● Monitoring: Once diagnosed, baseline CD4 count, HIV RNA viral load, and genotypic
resistance testing should be obtained.

Management and Treatment

● cART: All children should be started on cART immediately upon diagnosis,

regardless of viral load or CD4 count. Standard regimens include at least three drugs
from two different classes: typically a dual NRTI backbone (e.g., abacavir or tenofovir +
lamivudine or emtricitabine) combined with an integrase inhibitor (INSTI), a
nonnucleoside reverse transcriptase inhibitor (NNRTI), or a boosted protease inhibitor
(PI).
● Prophylaxis: TMP-SMX is initiated to prevent PJP in all HIV-infected infants under 1
year old regardless of CD4 count, and in older children based on severe CD4 depletion.
Azithromycin/clarithromycin is used for MAC prophylaxis in severely immunosuppressed
patients.
● Immunizations: Routine vaccines are administered, but live vaccines (MMR,
Varicella) are contraindicated in severely immunocompromised children. They may
be given to HIV-infected children with restored or preserved immunity (e.g., CD4 >15%
or absolute CD4 >500 cells/µL for ages 1-5).

Prevention

● Vertical Transmission: All pregnant individuals should be tested and treated with
suppressive cART.
○ Low-Risk Infants (mother virologically suppressed on cART): Receive 2-4 weeks
of prophylactic Zidovudine.
○ High-Risk Infants (mother unsuppressed or no prenatal care): Receive 6 weeks
of 3-drug presumptive HIV therapy (e.g., Zidovudine + Lamivudine + Nevirapine
or Raltegravir).
● Infant Feeding: In resource-rich settings, formula/replacement feeding eliminates the
risk of postnatal transmission and is recommended if the mother is unsuppressed.
 However, parents with sustained undetectable viral loads who choose to breastfeed
should be supported and monitored closely, as the transmission risk is <1%.
● Sexual Transmission: Barrier protection (condoms) and Preexposure Prophylaxis
(PrEP) using oral tenofovir/emtricitabine or injectable cabotegravir are highly effective
(70-92%) for adolescents at high risk. Postexposure prophylaxis (PEP) with a 3-drug
regimen should be initiated within 72 hours of a high-risk exposure.

Prognosis The prognosis has drastically improved with the advent of cART; mortality has
declined by >90%, and most perinatally infected children now survive into adulthood. A
sustained undetectable viral load and normal CD4 count correlate with near-normal life
expectancy.